This aligns with findings in other disorders where male sex is considered a risk factor, such as gout, aortic abdominal aneurysm and COVID19, in which the NLRP3 inflammasome was found to be overactivated in males and linked to worse disease outcomes [38, 39]. The gene discussed is NLRP3; the disease is COVID-19.